S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Critical asset just had biggest fall on record (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Critical asset just had biggest fall on record (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Critical asset just had biggest fall on record (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Critical asset just had biggest fall on record (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands
NASDAQ:ZYXI

Zynex (ZYXI) Stock Price, News & Analysis

$13.56
+0.07 (+0.52%)
(As of 02/29/2024 ET)
Today's Range
$13.28
$13.57
50-Day Range
$9.86
$13.74
52-Week Range
$6.88
$14.75
Volume
231,481 shs
Average Volume
240,270 shs
Market Capitalization
$459.68 million
P/E Ratio
31.53
Dividend Yield
N/A
Price Target
$20.33

Zynex MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
50.0% Upside
$20.33 Price Target
Short Interest
Bearish
30.37% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.68mentions of Zynex in the last 14 days
Based on 12 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
37.50%
From $0.40 to $0.55 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.26 out of 5 stars

Medical Sector

358th out of 957 stocks

Electromedical Equipment Industry

3rd out of 20 stocks


ZYXI stock logo

About Zynex Stock (NASDAQ:ZYXI)

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

ZYXI Stock Price History

ZYXI Stock News Headlines

Zynex: Q4 Earnings Insights
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Earnings Preview: Zynex
Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Zynex Introduces New Products
Zynex Introduces New Products
Zynex Says FDA Clears M-Wave Neuromuscular Electrical Stimulation Device
3 Unloved Growth Stocks Poised for a Major Turnaround
Zynex To Buy Back Up To $20 Mln Of Common Stock
Zynex Announces Review of Strategic Alternatives
See More Headlines
Receive ZYXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zynex and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/13/2023
Today
3/01/2024
Next Earnings (Estimated)
3/04/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:ZYXI
Fax
N/A
Employees
900
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$20.33
High Stock Price Target
$28.00
Low Stock Price Target
$13.00
Potential Upside/Downside
+50.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$17.05 million
Pretax Margin
10.96%

Debt

Sales & Book Value

Annual Sales
$158.17 million
Cash Flow
$0.54 per share
Book Value
$1.77 per share

Miscellaneous

Free Float
18,118,000
Market Cap
$459.68 million
Optionable
Optionable
Beta
0.49
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report














ZYXI Stock Analysis - Frequently Asked Questions

Should I buy or sell Zynex stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Zynex in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ZYXI shares.
View ZYXI analyst ratings
or view top-rated stocks.

What is Zynex's stock price target for 2024?

3 analysts have issued twelve-month price objectives for Zynex's stock. Their ZYXI share price targets range from $13.00 to $28.00. On average, they predict the company's stock price to reach $20.33 in the next year. This suggests a possible upside of 50.0% from the stock's current price.
View analysts price targets for ZYXI
or view top-rated stocks among Wall Street analysts.

How have ZYXI shares performed in 2024?

Zynex's stock was trading at $10.89 at the beginning of 2024. Since then, ZYXI stock has increased by 24.5% and is now trading at $13.56.
View the best growth stocks for 2024 here
.

When is Zynex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, March 4th 2024.
View our ZYXI earnings forecast
.

How were Zynex's earnings last quarter?

Zynex, Inc. (NASDAQ:ZYXI) released its quarterly earnings data on Monday, March, 13th. The company reported $0.20 EPS for the quarter, topping analysts' consensus estimates of $0.19 by $0.01. The business had revenue of $48.81 million for the quarter, compared to analysts' expectations of $49.65 million. Zynex had a net margin of 8.59% and a trailing twelve-month return on equity of 25.38%.

What ETF holds Zynex's stock ?

Syntax Stratified SmallCap ETF holds 8,191 shares of ZYXI stock, representing 0.42% of its portfolio.

What guidance has Zynex issued on next quarter's earnings?

Zynex updated its first quarter 2024 earnings guidance on Thursday, February, 29th. The company provided earnings per share (EPS) guidance of 0.030- for the period, compared to the consensus estimate of 0.040. The company issued revenue guidance of $47.5 million-, compared to the consensus revenue estimate of $47.7 million.

What is Thomas Sandgaard's approval rating as Zynex's CEO?

81 employees have rated Zynex Chief Executive Officer Thomas Sandgaard on Glassdoor.com. Thomas Sandgaard has an approval rating of 87% among the company's employees.

Who are Zynex's major shareholders?

Zynex's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (3.48%), HAP Trading LLC (0.00%), Northern Trust Corp (0.56%), GSA Capital Partners LLP (0.47%), Goldman Sachs Group Inc. (0.42%) and Charles Schwab Investment Management Inc. (0.37%). Insiders that own company stock include Anna Lucsok, Daniel J Moorhead and Thomas Sandgaard.
View institutional ownership trends
.

How do I buy shares of Zynex?

Shares of ZYXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ZYXI) was last updated on 3/1/2024 by MarketBeat.com Staff